Tyler Engel

Tyler provides a variety of skills, intelligence, and market strategy with a specialty in prescription drugs to a broad range of clients, including health plans, hospital systems, pharmaceutical companies, medical device manufacturers, healthcare industry trade organizations, disease and medical management vendors, and other healthcare providers.

For over a decade, he has helped these healthcare stakeholders address many new and arising challenges in the following areas:

• Market access strategy
• Medicare Part D filings
• Health Economics and Outcomes Research (HEOR)
• Evaluation of the cost effectiveness of care management programs
• Policy research and analysis
• Impact of the Inflation Reduction Act on Medicare Part D